Home/Shorla Oncology/Sharon Cunningham
SC

Sharon Cunningham

CEO & Co-Founder

Shorla Oncology

Therapeutic Areas

Shorla Oncology Pipeline

DrugIndicationPhase
Nelarabine Injection (larger vial)T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL)Approved